Annual FCF
$145.34 M
+$80.19 M+123.09%
31 December 2023
Summary:
Amphastar Pharmaceuticals annual free cash flow is currently $145.34 million, with the most recent change of +$80.19 million (+123.09%) on 31 December 2023. During the last 3 years, it has risen by +$121.93 million (+520.81%). AMPH annual FCF is now at all-time high.AMPH Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
$46.17 M
-$16.90 M-26.79%
30 September 2024
Summary:
Amphastar Pharmaceuticals quarterly free cash flow is currently $46.17 million, with the most recent change of -$16.90 million (-26.79%) on 30 September 2024. Over the past year, it has dropped by -$7.97 million (-14.72%). AMPH quarterly FCF is now -26.79% below its all-time high of $63.06 million, reached on 30 June 2024.AMPH Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
$170.15 M
-$7.97 M-4.48%
30 September 2024
Summary:
Amphastar Pharmaceuticals TTM free cash flow is currently $170.15 million, with the most recent change of -$7.97 million (-4.48%) on 30 September 2024. Over the past year, it has increased by +$30.32 million (+21.69%). AMPH TTM FCF is now -4.48% below its all-time high of $178.13 million, reached on 30 June 2024.AMPH TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AMPH Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +123.1% | -14.7% | +21.7% |
| 3 y3 years | +520.8% | +1092.9% | +282.0% |
| 5 y5 years | +1786.6% | +323.2% | +5767.4% |
AMPH Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +520.8% | -26.8% | +1092.9% | -4.5% | +282.0% |
| 5 y | 5 years | at high | +1786.6% | -26.8% | +323.2% | -4.5% | +1680.2% |
| alltime | all time | at high | +640.4% | -26.8% | +323.2% | -4.5% | +835.3% |
Amphastar Pharmaceuticals Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $46.17 M(-26.8%) | $170.15 M(-4.5%) |
| June 2024 | - | $63.06 M(+35.6%) | $178.13 M(+10.7%) |
| Mar 2024 | - | $46.50 M(+222.4%) | $160.93 M(+10.7%) |
| Dec 2023 | $145.34 M(+123.1%) | $14.42 M(-73.4%) | $145.34 M(+3.9%) |
| Sept 2023 | - | $54.14 M(+18.0%) | $139.83 M(+39.2%) |
| June 2023 | - | $45.87 M(+48.4%) | $100.44 M(+95.3%) |
| Mar 2023 | - | $30.91 M(+246.6%) | $51.43 M(-21.1%) |
| Dec 2022 | $65.15 M(-7.6%) | $8.92 M(-39.6%) | $65.15 M(-27.4%) |
| Sept 2022 | - | $14.75 M(-568.8%) | $89.79 M(+27.6%) |
| June 2022 | - | -$3.15 M(-107.1%) | $70.39 M(-29.6%) |
| Mar 2022 | - | $44.63 M(+33.0%) | $99.96 M(+41.7%) |
| Dec 2021 | $70.54 M(+201.3%) | $33.56 M(-821.8%) | $70.54 M(+58.4%) |
| Sept 2021 | - | -$4.65 M(-117.6%) | $44.54 M(-14.9%) |
| June 2021 | - | $26.42 M(+73.7%) | $52.37 M(+16.0%) |
| Mar 2021 | - | $15.21 M(+101.0%) | $45.15 M(+92.8%) |
| Dec 2020 | $23.41 M(>+9900.0%) | $7.56 M(+138.2%) | $23.41 M(+78.9%) |
| Sept 2020 | - | $3.18 M(-83.5%) | $13.09 M(-221.6%) |
| June 2020 | - | $19.20 M(-394.1%) | -$10.77 M(-188.4%) |
| Mar 2020 | - | -$6.53 M(+136.7%) | $12.18 M(+5785.5%) |
| Dec 2019 | $207.00 K(-102.4%) | -$2.76 M(-86.7%) | $207.00 K(-92.9%) |
| Sept 2019 | - | -$20.68 M(-149.1%) | $2.90 M(-89.1%) |
| June 2019 | - | $42.15 M(-327.8%) | $26.73 M(-215.5%) |
| Mar 2019 | - | -$18.50 M(>+9900.0%) | -$23.14 M(+168.6%) |
| Dec 2018 | -$8.62 M | -$65.00 K(-102.1%) | -$8.62 M(-3.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2018 | - | $3.15 M(-140.8%) | -$8.90 M(-57.6%) |
| June 2018 | - | -$7.72 M(+93.9%) | -$20.99 M(+39.9%) |
| Mar 2018 | - | -$3.98 M(+1027.5%) | -$15.00 M(-465.0%) |
| Dec 2017 | $4.11 M(-76.1%) | -$353.00 K(-96.1%) | $4.11 M(-68.7%) |
| Sept 2017 | - | -$8.94 M(+417.7%) | $13.13 M(-21.2%) |
| June 2017 | - | -$1.73 M(-111.4%) | $16.67 M(-25.3%) |
| Mar 2017 | - | $15.13 M(+74.5%) | $22.32 M(+30.0%) |
| Dec 2016 | $17.18 M(-423.2%) | $8.67 M(-260.4%) | $17.18 M(+122.3%) |
| Sept 2016 | - | -$5.40 M(-237.6%) | $7.73 M(-37.5%) |
| June 2016 | - | $3.93 M(-60.7%) | $12.37 M(+64.8%) |
| Mar 2016 | - | $9.98 M(-1376.7%) | $7.51 M(-241.2%) |
| Dec 2015 | -$5.32 M(-1061.1%) | -$782.00 K(+3.0%) | -$5.32 M(+413.0%) |
| Sept 2015 | - | -$759.00 K(-19.0%) | -$1.04 M(-111.3%) |
| June 2015 | - | -$937.00 K(-67.0%) | $9.13 M(+17.4%) |
| Mar 2015 | - | -$2.84 M(-181.1%) | $7.78 M(+1306.3%) |
| Dec 2014 | $553.00 K(-95.7%) | $3.50 M(-62.8%) | $553.00 K(-67.7%) |
| Sept 2014 | - | $9.41 M(-510.2%) | $1.71 M(-114.8%) |
| June 2014 | - | -$2.29 M(-77.2%) | -$11.53 M(-251.5%) |
| Mar 2014 | - | -$10.06 M(-316.1%) | $7.61 M(-40.3%) |
| Dec 2013 | $12.74 M(-147.4%) | $4.66 M(-221.4%) | $12.74 M(+57.6%) |
| Sept 2013 | - | -$3.83 M(-122.8%) | $8.08 M(-32.2%) |
| June 2013 | - | $16.85 M(-441.6%) | $11.92 M(-341.6%) |
| Mar 2013 | - | -$4.93 M | -$4.93 M |
| Dec 2012 | -$26.89 M(-421.0%) | - | - |
| Dec 2011 | $8.38 M | - | - |
FAQ
- What is Amphastar Pharmaceuticals annual free cash flow?
- What is the all time high annual FCF for Amphastar Pharmaceuticals?
- What is Amphastar Pharmaceuticals annual FCF year-on-year change?
- What is Amphastar Pharmaceuticals quarterly free cash flow?
- What is the all time high quarterly FCF for Amphastar Pharmaceuticals?
- What is Amphastar Pharmaceuticals quarterly FCF year-on-year change?
- What is Amphastar Pharmaceuticals TTM free cash flow?
- What is the all time high TTM FCF for Amphastar Pharmaceuticals?
- What is Amphastar Pharmaceuticals TTM FCF year-on-year change?
What is Amphastar Pharmaceuticals annual free cash flow?
The current annual FCF of AMPH is $145.34 M
What is the all time high annual FCF for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals all-time high annual free cash flow is $145.34 M
What is Amphastar Pharmaceuticals annual FCF year-on-year change?
Over the past year, AMPH annual free cash flow has changed by +$80.19 M (+123.09%)
What is Amphastar Pharmaceuticals quarterly free cash flow?
The current quarterly FCF of AMPH is $46.17 M
What is the all time high quarterly FCF for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals all-time high quarterly free cash flow is $63.06 M
What is Amphastar Pharmaceuticals quarterly FCF year-on-year change?
Over the past year, AMPH quarterly free cash flow has changed by -$7.97 M (-14.72%)
What is Amphastar Pharmaceuticals TTM free cash flow?
The current TTM FCF of AMPH is $170.15 M
What is the all time high TTM FCF for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals all-time high TTM free cash flow is $178.13 M
What is Amphastar Pharmaceuticals TTM FCF year-on-year change?
Over the past year, AMPH TTM free cash flow has changed by +$30.32 M (+21.69%)